Artwork

Indhold leveret af DKBmed. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af DKBmed eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Newer Options for Treatment-Experienced Patients Podcast

33:52
 
Del
 

Manage episode 343699555 series 2065653
Indhold leveret af DKBmed. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af DKBmed eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV drug resistance requires a therapeutic regimen individualized for each patient’s ART history. How will new and in-development agents affect the equation?

Which drug combinations are right? Where does the balance between side effects and adherence lie?

These are some of the questions Dr. Brian Wood from the Division of Allergy and Infectious Diseases at the University of Washington in Seattle addresses in this eHIV Review podcast.


Take our post-test to claim CME credits.

To read a companion newsletter click here.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

214 episoder

Artwork
iconDel
 
Manage episode 343699555 series 2065653
Indhold leveret af DKBmed. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af DKBmed eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV drug resistance requires a therapeutic regimen individualized for each patient’s ART history. How will new and in-development agents affect the equation?

Which drug combinations are right? Where does the balance between side effects and adherence lie?

These are some of the questions Dr. Brian Wood from the Division of Allergy and Infectious Diseases at the University of Washington in Seattle addresses in this eHIV Review podcast.


Take our post-test to claim CME credits.

To read a companion newsletter click here.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

214 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning